Study of HRS-5965 in Healthy Subjects and Subjects With Renal Insufficiency

NCT05505955 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

83

Enrollment

INDUSTRY

Sponsor class

Conditions

Glomerulonephritis

Interventions

DRUG: HRS-5965
DRUG: Placebo

Sponsor

Chengdu Suncadia Medicine Co., Ltd.